TRACON Pharmaceuticals Inc (NASDAQ:TCON)
| 0.1752 BATS BZX Real-Time Price As of Sep 29 |  0.00 / 0.00%Today’s Change | 0.17 Today|||52-Week Range 2.19 | -88.24% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 7.9M | 3.4M | 8.8M | 3.0M | |
| Depreciation And Amortization | 51.0K | 94.0K | 48.0K | 28.0K | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 31.3M | 29.3M | 26.9M | 37.7M | ||
| Research And Development | 25.7M | 21.6M | 19.4M | 30.5M | ||
| Total Operating Expenses | 31.4M | 29.4M | 27.0M | 37.7M | ||
| Non-Operating Expenses | Operating Income | -23.5M | -26.0M | -18.2M | -34.7M | |
| Extraordinary Charge | -65.0K | 0.00 | 0.00 | 0.00 | ||
| Interest Expense On Debt | 923.0K | 1.1M | 886.0K | 231.0K | ||
| Other Expenses | 45.0K | 87.0K | -7.0K | 12.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -24.4M | -27.0M | -19.1M | -35.0M | |
| Net Income | -24.4M | -27.0M | -19.1M | -35.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 11.1M | 12.7M | 16.8M | 26.9M | |
| Shares To Calculate EPS Diluted | 11.1M | 12.7M | 16.8M | 26.9M | ||
| Earnings Per Share | EPS | -$2.20 | -$2.13 | -$1.14 | -$1.30 | |
| EPS Diluted | -$2.20 | -$2.13 | -$1.14 | -$1.30 | ||
